Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Approaches designed to arrest beta-cell apoptosis could be a “significant new development in the management of type 2 diabetes.
Read More »Issue 144 Item 10 Rosuvastatin Reduces LDL Cholesterol and Improves Lipid Profil
Rosuvastatin (Crestor; AstraZeneca) is more effective than atorvastatin (Lipitor; Pfizer, Inc.)
Read More »Issue 144 Item 9 Obesity & Poor Glycemic Control Common for African-American Typ
Average baseline HbA1c levels were 9.9% in patients aged less than 30 years.
Read More »Issue 144 Item 8 Pancreatic Beta Cell Destruction Prevented by Natural Killer T
Natural killer T cells (NKT cells) prevented the development of diabetes, according to a report from researchers in France.
Read More »Issue 144 Item 7 Lack of Diabetes Patient Education Standardization Responsible
Physicians need to take a more active role.
Read More »Issue 144 Item 6 Exercise-Induced Hypertension Flags Risk of Vascular Disease
Exercise-induced hypertension is a marker for vascular disease.
Read More »Issue 144 Item 5 Focus Shifting to ‘Non-HDL’ Lipids
Non-HDL cholesterol—total cholesterol minus HDL cholesterol—will be a major secondary therapeutic target .
Read More »Issue 142 Item 7 Unplanned Dialysis Leeds to Severely Impaired Quality of Life
When the first session has not been anticipated and planned for, the QOL of patients is severely impaired.
Read More »Issue 142 Item 6 Outcomes Improve When Using a New Interactive Technique
Simple communication techniques make physicians more effective teachers.
Read More »Issue 142 Item 5 School Problems for Children with Type 1 Due to Other Factors
Differences in academic performance between diabetic and non-diabetic children stem mostly from other factors, such as family income and behavioral problems.
Read More »